Difficulty: Medium
Average Score: 70%
Practice
Propranolol should not be prescribed for a patient of angina pectoris who is already receiving
Correct answer
C
Rationale
In this scenario, the correct answer is C) Verapamil. Propranolol, a beta-blocker, should not be prescribed for a patient with angina pectoris who is already receiving Verapamil, a calcium channel blocker. This combination can cause additive negative effects on the heart, such as excessive slowing of the heart rate and decreased cardiac contractility, potentially leading to serious cardiac complications.
Nifedipine (Option A), Felodipine (Option B), and Isosorbide mononitrate (Option D) are not contraindicated with Propranolol in the context of treating angina pectoris. Nifedipine and Felodipine are also calcium channel blockers but belong to the dihydropyridine class, which does not have the same negative interactions with beta-blockers like Propranolol. Isosorbide mononitrate is a nitrate that is commonly used in combination with beta-blockers for managing angina.
Educationally, understanding the interactions between different classes of cardiovascular drugs is crucial for safe and effective pharmacological management. It is essential for nurses to be aware of potential drug interactions to prevent adverse outcomes and to ensure optimal patient care. In this case, the rationale emphasizes the importance of knowing which drug combinations to avoid in patients with angina pectoris to prevent harmful effects on the cardiovascular system.
Nifedipine (Option A), Felodipine (Option B), and Isosorbide mononitrate (Option D) are not contraindicated with Propranolol in the context of treating angina pectoris. Nifedipine and Felodipine are also calcium channel blockers but belong to the dihydropyridine class, which does not have the same negative interactions with beta-blockers like Propranolol. Isosorbide mononitrate is a nitrate that is commonly used in combination with beta-blockers for managing angina.
Educationally, understanding the interactions between different classes of cardiovascular drugs is crucial for safe and effective pharmacological management. It is essential for nurses to be aware of potential drug interactions to prevent adverse outcomes and to ensure optimal patient care. In this case, the rationale emphasizes the importance of knowing which drug combinations to avoid in patients with angina pectoris to prevent harmful effects on the cardiovascular system.